Compare PICS & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PICS | PAHC |
|---|---|---|
| Founded | 2012 | 1946 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | N/A | 2014 |
| Metric | PICS | PAHC |
|---|---|---|
| Price | $11.84 | $32.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $22.00 | ★ $41.25 |
| AVG Volume (30 Days) | ★ 348.6K | 250.7K |
| Earning Date | 05-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | N/A | ★ 1883.33 |
| EPS | N/A | ★ 1.90 |
| Revenue | N/A | ★ $833,350,000.00 |
| Revenue This Year | $33.65 | $17.03 |
| Revenue Next Year | $39.85 | $3.82 |
| P/E Ratio | $29.44 | ★ $17.04 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $8.32 | $25.58 |
| 52 Week High | $18.49 | $60.08 |
| Indicator | PICS | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 61.59 | 44.94 |
| Support Level | $11.26 | $30.46 |
| Resistance Level | $13.80 | $34.49 |
| Average True Range (ATR) | 0.71 | 1.22 |
| MACD | 0.18 | 0.46 |
| Stochastic Oscillator | 86.54 | 40.30 |
PicS NV is a digital payments company. The company operates a peer-to-peer (P2P) transfer platform that enables individuals to send money via mobile devices. It provides digital wallets, instant payments (Pix), P2P transfers, credit cards, loans, investments, insurance, and SMB payment solutions. The company has four reportable segments: Consumer Banking, Small and Medium-Sized Businesses, Audiences and Ecosystem Integration, and Institutional. The majority of the company's revenue is derived from the Consumer Banking segment, which generates revenue from various transaction activities occurring in the digital wallet, such as Pix, peer-to-peer (P2P) transfers, and bill payments.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.